References
- Mehta PR, Iacoangeli A, Opie-Martin S, van Vugt JJFA, Khleifat AA, Bredin A, et al. The impact of age on genetic testing decisions in amyotrophic lateral sclerosis. Brain. 2022;145:4440–7.
- Vázquez-Costa JF, Borrego-Hernández D, Paradas C, Gómez-Caravaca MT, Rojas-Garcia R, Varona L, et al. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease. Eur J Neurol. 2023;30:861–71.
- Gagliardi D, Ahmadinejad M, Del Bo R, Meneri M, Comi GP, Corti S, et al. Homozygous SOD1 variation L144S produces a severe form of amyotrophic lateral sclerosis in an Iranian family. Neurol Genet. 2022;8:e645.
- Souza PVS, Pinto WBVR, Farias IB, Farias IB, Badia BML, Pinto IFN, et al. Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity? Orphanet J Rare Dis. 2021;16:360.
- Fahmy N, Müller K, Andersen PM, Marklund SL, Otto M, Ludolph AC, et al. A novel homozygous p.Ser69Pro SOD1 mutation causes severe young‑onset ALS with decreased enzyme activity. J Neurol. 2023;270:1770–3. Epub 2022 Dec 6
- Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordström U, Basal A, et al. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain. 2022;145:872–8.
- Gonçalves JPN, Leoni TB, Martins MP, Peluzzo TM, Dourado-Junior MET, Saute JAM, et al. Genetic epidemiology of familial ALS in Brazil. Neurobiol Aging. 2021;102:227.e1–227.e4.
- de Fuenmayor-Fernández de la Hoz CP, Hernández-Laín A, Olivé M, Arteche López A, Esteban J, Domínguez-González C, et al. SOD1 mutations in adult-onset distal spinal muscular atrophy. Eur J Neurol. 2020;27:e75–e76.
- Andersen PM, Nordström U, Tsiakas K, Johannsen J, Volk AE, Bierhals T, et al. Phenotype in an infant with SOD1 homozygous truncating mutation. N Engl J Med. 2019;381:486–8.